Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
J129444-5mg | 5mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $34.90 | |
J129444-25mg | 25mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $142.90 | |
J129444-100mg | 100mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $474.90 | |
J129444-250mg | 250mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $1,068.90 |
Potent MAGL inhibitor
Synonyms | JZL184|1101854-58-3|JZL 184|JZL-184|4-nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate|7MZ1I2J68A|CHEMBL576786|4-Nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate|1-Piperidinecarboxylic ac |
---|---|
Specifications & Purity | ≥97% |
Storage Temp | Store at -20°C,Argon charged |
Shipped In | Dry ice |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Inhibitor of Monoacylglycerol lipase |
Product Description | application: JZL 184 has been used as an inhibitor of monoacylglycerol lipase to study its effect on human osteoblast differentiation and proliferation and postsynaptic neurons. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | (4-nitrophenyl) 4-[bis(1,3-benzodioxol-5-yl)-hydroxymethyl]piperidine-1-carboxylate |
---|---|
INCHI | InChI=1S/C27H24N2O9/c30-26(38-21-5-3-20(4-6-21)29(32)33)28-11-9-17(10-12-28)27(31,18-1-7-22-24(13-18)36-15-34-22)19-2-8-23-25(14-19)37-16-35-23/h1-8,13-14,17,31H,9-12,15-16H2 |
InChi Key | SEGYOKHGGFKMCX-UHFFFAOYSA-N |
Canonical SMILES | C1CN(CCC1C(C2=CC3=C(C=C2)OCO3)(C4=CC5=C(C=C4)OCO5)O)C(=O)OC6=CC=C(C=C6)[N+](=O)[O-] |
Isomeric SMILES | C1CN(CCC1C(C2=CC3=C(C=C2)OCO3)(C4=CC5=C(C=C4)OCO5)O)C(=O)OC6=CC=C(C=C6)[N+](=O)[O-] |
PubChem CID | 25021165 |
Molecular Weight | 520.5 |
CAS Registry No. | 1101854-58-3 |
---|---|
Wikipedia | JZL184 |
PubChem CID | 25021165 |
ChEMBL Ligand | CHEMBL576786 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
I2205056 | Certificate of Analysis | Jun 18, 2024 | J129444 |
I2205057 | Certificate of Analysis | Jun 18, 2024 | J129444 |
I2205058 | Certificate of Analysis | Jun 18, 2024 | J129444 |
I2205101 | Certificate of Analysis | Jun 18, 2024 | J129444 |
Solubility | Solvent:DMSO, Max Conc. mg/mL: 52.05, Max Conc. mM: 100 |
---|---|
Sensitivity | Moisture sensitive. |
1. Long JZ, Nomura DK, Vann RE, Walentiny DM, Booker L, Jin X, Burston JJ, Sim-Selley LJ, Lichtman AH, Wiley JL et al.. (2009) Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo.. Proc Natl Acad Sci USA, 106 (48): (20270-5). [PMID:19918051] |
2. Long JZ, Nomura DK, Cravatt BF. (2009) Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism.. Chem Biol, 16 (7): (744-53). [PMID:19635411] |
3. Navarro-Romero A et al.. (2022) Cannabinoid signaling modulation through JZL184 restores key phenotypes of a mouse model for Williams-Beuren syndrome.. Elife, 11 [PMID:36217821] |
4. Bluett RJ et al.. (2017) Endocannabinoid signalling modulates susceptibility to traumatic stress exposure.. Nat Commun, 8 (14782). [PMID:28348378] |